Annamaria Balogh
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cardiovascular risk and achievement of target levels in low-density lipoprotein cholesterol in people living with HIV: insights from the DUALIS study.
Journal: HIV research & clinical practice
Published: July 23, 2025
Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes.
Journal: HIV research & clinical practice
Published: March 02, 2022
Inadequate PTH Response to Hypocalcemia in People Living with HIV.
Journal: Current HIV research
Published: September 01, 2021
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance.
Journal: AIDS research and therapy
Published: May 08, 2021
Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV-infection.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: January 21, 2021
HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'.
Journal: Infection
Published: August 05, 2020
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study.
Journal: The Journal of antimicrobial chemotherapy
Published: July 08, 2020
Author Correction: Proteomic and Transcriptomic Changes in Hibernating Grizzly Bears Reveal Metabolic and Signaling Pathways that Protect against Muscle Atrophy.
Journal: Scientific reports
Published: March 05, 2020
Proteomic and Transcriptomic Changes in Hibernating Grizzly Bears Reveal Metabolic and Signaling Pathways that Protect against Muscle Atrophy.
Journal: Scientific reports
Published: September 25, 2019
Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study.
Journal: Patient preference and adherence
Published: November 30, 2017
Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results.
Journal: Antiviral therapy
Published: August 28, 2016
Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study.
Journal: Antiviral therapy
Published: March 31, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026